1. Remnant cholesterol in patients with established cardiovascular disease predicts cardiovascular events both among patients with type 2 diabetes and among non-diabetic subjects. (14th October 2021) Authors: Mader, A; Sprenger, L; Vonbank, A; Larcher, B; Maechler, M; Mutschlechner, B; Benda, M; Leiherer, A; Muendlein, A; Drexel, H; Saely, C H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The ceramide- and phosphatidylcholine- based Coronary Event Risk Test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes. (14th October 2021) Authors: Leiherer, A; Muendlein, A; Saely, C H; Larcher, B; Mader, A; Maechler, M; Sprenger, L; Mutschlechner, B; Benda, M; Laaksonen, R; Laaperi, M; Jylha, A; Fraunberger, P; Drexel, H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The new myokine myonectin is significantly associated with type 2 diabetes in elderly patients. (14th October 2021) Authors: Leiherer, A; Muendlein, A; Geiger, K; Saely, C H; Larcher, B; Mader, A; Maechler, M; Sprenger, L; Mutschlechner, B; Benda, M; Fraunberger, P; Drexel, H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Type 2 diabetes and risk of major cardiovascular events in peripheral artery disease versus coronary artery disease patients. (14th October 2021) Authors: Saely, C H; Vonbank, A; Larcher, B; Mader, A; Maechler, M; Sprenger, L; Mutschlechner, B; Benda, M; Leiherer, A; Muendlein, A; Drexel, H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Type 2 diabetes significantly modulates the power of lipoprotein(a) to predict cardiovascular events and mortality in young coronary artery disease patients. (14th October 2021) Authors: Mader, A; Maechler, M; Larcher, B; Sprenger, L; Mutschlechner, B; Benda, M; Leiherer, A; Muendlein, A; Vonbank, A; Drexel, H; Saely, C H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Type 2 diabetes, chronic kidney disease and major cardiovascular events in patients with established coronary artery disease. (14th October 2021) Authors: Sprenger, L; Vonbank, A; Larcher, B; Mader, A; Maechler, M; Mutschlechner, B; Benda, M; Leiherer, A; Muendlein, A; Drexel, H; Saely, C H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗